Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ben A. Oostra is active.

Publication


Featured researches published by Ben A. Oostra.


Nature Genetics | 2009

Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts

Yurii S. Aulchenko; Samuli Ripatti; Ida Lindqvist; Dorret I. Boomsma; Iris M. Heid; Peter P. Pramstaller; Brenda W.J.H. Penninx; A. Cecile J. W. Janssens; James F. Wilson; Tim D. Spector; Nicholas G. Martin; Nancy L. Pedersen; Kirsten Ohm Kyvik; Jaakko Kaprio; Albert Hofman; Nelson B. Freimer; Marjo-Riitta Järvelin; Ulf Gyllensten; Harry Campbell; Igor Rudan; Åsa Johansson; Fabio Marroni; Caroline Hayward; Veronique Vitart; Inger Jonasson; Cristian Pattaro; Alan F. Wright; Nicholas D. Hastie; Irene Pichler; Andrew A. Hicks

Recent genome-wide association (GWA) studies of lipids have been conducted in samples ascertained for other phenotypes, particularly diabetes. Here we report the first GWA analysis of loci affecting total cholesterol (TC), low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol and triglycerides sampled randomly from 16 population-based cohorts and genotyped using mainly the Illumina HumanHap300-Duo platform. Our study included a total of 17,797–22,562 persons, aged 18–104 years and from geographic regions spanning from the Nordic countries to Southern Europe. We established 22 loci associated with serum lipid levels at a genome-wide significance level (P < 5 × 10−8), including 16 loci that were identified by previous GWA studies. The six newly identified loci in our cohort samples are ABCG5 (TC, P = 1.5 × 10−11; LDL, P = 2.6 × 10−10), TMEM57 (TC, P = 5.4 × 10−10), CTCF-PRMT8 region (HDL, P = 8.3 × 10−16), DNAH11 (LDL, P = 6.1 × 10−9), FADS3-FADS2 (TC, P = 1.5 × 10−10; LDL, P = 4.4 × 10−13) and MADD-FOLH1 region (HDL, P = 6 × 10−11). For three loci, effect sizes differed significantly by sex. Genetic risk scores based on lipid loci explain up to 4.8% of variation in lipids and were also associated with increased intima media thickness (P = 0.001) and coronary heart disease incidence (P = 0.04). The genetic risk score improves the screening of high-risk groups of dyslipidemia over classical risk factors.


American Journal of Human Genetics | 2008

Three Genome-wide Association Studies and a Linkage Analysis Identify HERC2 as a Human Iris Color Gene

Manfred Kayser; Fan Liu; A. Cecile J. W. Janssens; Fernando Rivadeneira; Oscar Lao; Kate van Duijn; Mark Vermeulen; Pascal P. Arp; Mila Jhamai; Wilfred van IJcken; Johan T. den Dunnen; Simon Heath; Diana Zelenika; Dominiek D. G. Despriet; C. C. W. Klaver; Johannes R. Vingerling; Paulus T. V. M. de Jong; Albert Hofman; Yurii S. Aulchenko; André G. Uitterlinden; Ben A. Oostra; Cornelia van Duijn

Human iris color was one of the first traits for which Mendelian segregation was established. To date, the genetics of iris color is still not fully understood and is of interest, particularly in view of forensic applications. In three independent genome-wide association (GWA) studies of a total of 1406 persons and a genome-wide linkage study of 1292 relatives, all from the Netherlands, we found that the 15q13.1 region is the predominant region involved in human iris color. There were no other regions showing consistent genome-wide evidence for association and linkage to iris color. Single nucleotide polymorphisms (SNPs) in the HERC2 gene and, to a lesser extent, in the neighboring OCA2 gene were independently associated to iris color variation. OCA2 has been implicated in iris color previously. A replication study within two populations confirmed that the HERC2 gene is a new and significant determinant of human iris color variation, in addition to OCA2. Furthermore, HERC2 rs916977 showed a clinal allele distribution across 23 European populations, which was significantly correlated to iris color variation. We suggest that genetic variants regulating expression of the OCA2 gene exist in the HERC2 gene or, alternatively, within the 11.7 kb of sequence between OCA2 and HERC2, and that most iris color variation in Europeans is explained by those two genes. Testing markers in the HERC2-OCA2 region may be useful in forensic applications to predict eye color phenotypes of unknown persons of European genetic origin.


PLOS Genetics | 2009

Genetic determinants of circulating sphingolipid concentrations in European populations

Andrew A. Hicks; Peter P. Pramstaller; Åsa Johansson; Veronique Vitart; Igor Rudan; Peter Ugocsai; Yurii S. Aulchenko; Christopher S. Franklin; Gerhard Liebisch; Jeanette Erdmann; Inger Jonasson; Irina V. Zorkoltseva; Cristian Pattaro; Caroline Hayward; Aaron Isaacs; Christian Hengstenberg; Susan Campbell; Carsten Gnewuch; A. CecileJ.W. Janssens; Anatoly V. Kirichenko; Inke R. König; Fabio Marroni; Ozren Polašek; Ayse Demirkan; Ivana Kolcic; Christine Schwienbacher; Wilmar Igl; Zrinka Biloglav; Jacqueline C. M. Witteman; Irene Pichler

Sphingolipids have essential roles as structural components of cell membranes and in cell signalling, and disruption of their metabolism causes several diseases, with diverse neurological, psychiatric, and metabolic consequences. Increasingly, variants within a few of the genes that encode enzymes involved in sphingolipid metabolism are being associated with complex disease phenotypes. Direct experimental evidence supports a role of specific sphingolipid species in several common complex chronic disease processes including atherosclerotic plaque formation, myocardial infarction (MI), cardiomyopathy, pancreatic β-cell failure, insulin resistance, and type 2 diabetes mellitus. Therefore, sphingolipids represent novel and important intermediate phenotypes for genetic analysis, yet little is known about the major genetic variants that influence their circulating levels in the general population. We performed a genome-wide association study (GWAS) between 318,237 single-nucleotide polymorphisms (SNPs) and levels of circulating sphingomyelin (SM), dihydrosphingomyelin (Dih-SM), ceramide (Cer), and glucosylceramide (GluCer) single lipid species (33 traits); and 43 matched metabolite ratios measured in 4,400 subjects from five diverse European populations. Associated variants (32) in five genomic regions were identified with genome-wide significant corrected p-values ranging down to 9.08×10−66. The strongest associations were observed in or near 7 genes functionally involved in ceramide biosynthesis and trafficking: SPTLC3, LASS4, SGPP1, ATP10D, and FADS1–3. Variants in 3 loci (ATP10D, FADS3, and SPTLC3) associate with MI in a series of three German MI studies. An additional 70 variants across 23 candidate genes involved in sphingolipid-metabolizing pathways also demonstrate association (pu200a=u200a10−4 or less). Circulating concentrations of several key components in sphingolipid metabolism are thus under strong genetic control, and variants in these loci can be tested for a role in the development of common cardiovascular, metabolic, neurological, and psychiatric diseases.


PLOS Genetics | 2012

Common Genetic Determinants of Intraocular Pressure and Primary Open-Angle Glaucoma

Leonieke M. E. van Koolwijk; Wishal D. Ramdas; M. Kamran Ikram; Nomdo M. Jansonius; Francesca Pasutto; Pirro G. Hysi; Stuart MacGregor; Sarah F. Janssen; Alex W. Hewitt; Ananth C. Viswanathan; Jacoline B. ten Brink; S. Mohsen Hosseini; Najaf Amin; Dominiek D. G. Despriet; Jacqueline J. M. Willemse-Assink; Rogier Kramer; Fernando Rivadeneira; Maksim Struchalin; Yurii S. Aulchenko; Nicole Weisschuh; Matthias Zenkel; Christian Y. Mardin; Eugen Gramer; Ulrich Welge-Lüssen; Grant W. Montgomery; Francis Carbonaro; Terri L. Young; Céline Bellenguez; P. McGuffin; Paul J. Foster

Intraocular pressure (IOP) is a highly heritable risk factor for primary open-angle glaucoma and is the only target for current glaucoma therapy. The genetic factors which determine IOP are largely unknown. We performed a genome-wide association study for IOP in 11,972 participants from 4 independent population-based studies in The Netherlands. We replicated our findings in 7,482 participants from 4 additional cohorts from the UK, Australia, Canada, and the Wellcome Trust Case-Control Consortium 2/Blue Mountains Eye Study. IOP was significantly associated with rs11656696, located in GAS7 at 17p13.1 (pu200a=u200a1.4×10−8), and with rs7555523, located in TMCO1 at 1q24.1 (pu200a=u200a1.6×10−8). In a meta-analysis of 4 case-control studies (total Nu200a=u200a1,432 glaucoma cases), both variants also showed evidence for association with glaucoma (pu200a=u200a2.4×10−2 for rs11656696 and pu200a=u200a9.1×10−4 for rs7555523). GAS7 and TMCO1 are highly expressed in the ciliary body and trabecular meshwork as well as in the lamina cribrosa, optic nerve, and retina. Both genes functionally interact with known glaucoma disease genes. These data suggest that we have identified two clinically relevant genes involved in IOP regulation.


Journals of Gerontology Series A-biological Sciences and Medical Sciences | 2015

GWAS of Longevity in CHARGE Consortium Confirms APOE and FOXO3 Candidacy

Linda Broer; Aron S. Buchman; Joris Deelen; Daniel S. Evans; Jessica D. Faul; Kathryn L. Lunetta; Paola Sebastiani; Jennifer A. Smith; Albert V. Smith; Toshiko Tanaka; Lei Yu; Alice M. Arnold; Thor Aspelund; Emelia J. Benjamin; Philip L. De Jager; Gudny Eirkisdottir; Denis A. Evans; Melissa Garcia; Albert Hofman; Robert C. Kaplan; Sharon L.R. Kardia; Douglas P. Kiel; Ben A. Oostra; Eric S. Orwoll; Neeta Parimi; Bruce M. Psaty; Fernando Rivadeneira; Jerome I. Rotter; Sudha Seshadri; Andrew Singleton

BACKGROUNDnThe genetic contribution to longevity in humans has been estimated to range from 15% to 25%. Only two genes, APOE and FOXO3, have shown association with longevity in multiple independent studies.nnnMETHODSnWe conducted a meta-analysis of genome-wide association studies including 6,036 longevity cases, age ≥90 years, and 3,757 controls that died between ages 55 and 80 years. We additionally attempted to replicate earlier identified single nucleotide polymorphism (SNP) associations with longevity.nnnRESULTSnIn our meta-analysis, we found suggestive evidence for the association of SNPs near CADM2 (odds ratio [OR] = 0.81; p value = 9.66 × 10(-7)) and GRIK2 (odds ratio = 1.24; p value = 5.09 × 10(-8)) with longevity. When attempting to replicate findings earlier identified in genome-wide association studies, only the APOE locus consistently replicated. In an additional look-up of the candidate gene FOXO3, we found that an earlier identified variant shows a highly significant association with longevity when including published data with our meta-analysis (odds ratio = 1.17; p value = 1.85×10(-10)).nnnCONCLUSIONSnWe did not identify new genome-wide significant associations with longevity and did not replicate earlier findings except for APOE and FOXO3. Our inability to find new associations with survival to ages ≥90 years because longevity represents multiple complex traits with heterogeneous genetic underpinnings, or alternatively, that longevity may be regulated by rare variants that are not captured by standard genome-wide genotyping and imputation of common variants.


American Journal of Human Genetics | 2012

Genetic Adaptation of Fatty-Acid Metabolism: A Human-Specific Haplotype Increasing the Biosynthesis of Long-Chain Omega-3 and Omega-6 Fatty Acids

Adam Ameur; Stefan Enroth; Åsa Johansson; Ghazal Zaboli; Wilmar Igl; Anna Johansson; Manuel A. Rivas; Mark J. Daly; Gerd Schmitz; Andrew A. Hicks; Thomas Meitinger; Lars Feuk; Cornelia van Duijn; Ben A. Oostra; Peter P. Pramstaller; Igor Rudan; Alan F. Wright; James F. Wilson; Harry Campbell; Ulf Gyllensten

Omega-3 and omega-6 long-chain polyunsaturated fatty acids (LC-PUFAs) are essential for the development and function of the human brain. They can be obtained directly from food, e.g., fish, or synthesized from precursor molecules found in vegetable oils. To determine the importance of genetic variability to fatty-acid biosynthesis, we studied FADS1 and FADS2, which encode rate-limiting enzymes for fatty-acid conversion. We performed genome-wide genotyping (n = 5,652 individuals) and targeted resequencing (n = 960 individuals) of the FADS region in five European population cohorts. We also analyzed available genomic data from human populations, archaic hominins, and more distant primates. Our results show that present-day humans have two common FADS haplotypes-defined by 28 closely linked SNPs across 38.9 kb-that differ dramatically in their ability to generate LC-PUFAs. No independent effects on FADS activity were seen for rare SNPs detected by targeted resequencing. The more efficient, evolutionarily derived haplotype appeared after the lineage split leading to modern humans and Neanderthals and shows evidence of positive selection. This human-specific haplotype increases the efficiency of synthesizing essential long-chain fatty acids from precursors and thereby might have provided an advantage in environments with limited access to dietary LC-PUFAs. In the modern world, this haplotype has been associated with lifestyle-related diseases, such as coronary artery disease.


American Journal of Human Genetics | 2008

Fragile X-Related Proteins Regulate Mammalian Circadian Behavioral Rhythms

Jing Zhang; Zhe Fang; Corinne Jud; Mariska J. Vansteensel; Krista Kaasik; Cheng Chi Lee; Urs Albrecht; Filippo Tamanini; Johanna H. Meijer; Ben A. Oostra; David L. Nelson

Fragile X syndrome results from the absence of the fragile X mental retardation 1 (FMR1) gene product (FMRP). FMR1 has two paralogs in vertebrates: fragile X related gene 1 and 2 (FXR1 and FXR2). Here we show that Fmr1/Fxr2 double knockout (KO) and Fmr1 KO/Fxr2 heterozygous animals exhibit a loss of rhythmic activity in a light:dark (LD) cycle, and that Fmr1 or Fxr2 KO mice display a shorter free-running period of locomotor activity in total darkness (DD). Molecular analysis and in vitro electrophysiological studies suggest essentially normal function of cells in the suprachiasmatic nucleus (SCN) in Fmr1/Fxr2 double KO mice. However, the cyclical patterns of abundance of several core clock component messenger (m) RNAs are altered in the livers of double KO mice. Furthermore, FXR2P alone or FMRP and FXR2P together can increase PER1- or PER2-mediated BMAL1-Neuronal PAS2 (NPAS2) transcriptional activity in a dose-dependent manner. These data collectively demonstrate that FMR1 and FXR2 are required for the presence of rhythmic circadian behavior in mammals and suggest that this role may be relevant to sleep and other behavioral alterations observed in fragile X patients.


Human Molecular Genetics | 2009

A genome-wide association study of northwestern Europeans involves the C-type natriuretic peptide signaling pathway in the etiology of human height variation

Karol Estrada; Michael Krawczak; Stefan Schreiber; Kate van Duijn; Lisette Stolk; Joyce B. J. van Meurs; Fan Liu; Brenda W.J.H. Penninx; Jan Smit; Nicole Vogelzangs; Jouke-Jan Hottenga; Gonneke Willemsen; Eco J. C. de Geus; Mattias Lorentzon; Huberta von Eller-Eberstein; Paul Lips; Natascha Schoor; Victor J. M. Pop; Jules de Keijzer; Albert Hofman; Yurii S. Aulchenko; Ben A. Oostra; Claes Ohlsson; Dorret I. Boomsma; André G. Uitterlinden; Cornelia van Duijn; Fernando Rivadeneira; Manfred Kayser

Northwestern Europeans are among the tallest of human populations. The increase in body height in these people appears to have reached a plateau, suggesting the ubiquitous presence of an optimal environment in which genetic factors may have exerted a particularly strong influence on human growth. Therefore, we performed a genome-wide association study (GWAS) of body height using 2.2 million markers in 10 074 individuals from three Dutch and one German population-based cohorts. Upon genotyping, the 12 most significantly height-associated single nucleotide polymorphisms (SNPs) from this GWAS in 6912 additional individuals of Dutch and Swedish origin, a genetic variant (rs6717918) on chromosome 2q37.1 was found to be associated with height at a genome-wide significance level (Pcombined = 3.4 × 10−9). Notably, a second SNP (rs6718438) located ∼450 bp away and in strong LD (r2 = 0.77) with rs6717918 was previously found to be suggestive of a height association in 29 820 individuals of mainly northwestern European ancestry, and the over-expression of a nearby natriuretic peptide precursor type C (NPPC) gene, has been associated with overgrowth and skeletal anomalies. We also found a SNP (rs10472828) located on 5p14 near the natriuretic peptide receptor 3 (NPR3) gene, encoding a receptor of the NPPC ligand, to be associated with body height (Pcombined = 2.1 × 10−7). Taken together, these results suggest that variation in the C-type natriuretic peptide signaling pathway, involving the NPPC and NPR3 genes, plays an important role in determining human body height.


Journal of Psychiatric Research | 2013

Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study

Ayse Demirkan; Aaron Isaacs; Peter Ugocsai; Gerhard Liebisch; Maksim Struchalin; Igor Rudan; James F. Wilson; Peter P. Pramstaller; Ulf Gyllensten; Harry Campbell; Gerd Schmitz; Ben A. Oostra; Cornelia van Duijn

The central nervous system has the second highest concentration of lipids after adipose tissue. Alterations in neural membrane phospho- and sphingolipid composition can influence crucial intra- and intercellular signalling and alter the membranes properties. Recently, the polyunsaturated fatty acids (PUFA) hypothesis for depression suggests that phospho- and sphingolipid metabolism includes potential pathways for the disease. In 742 people from a Dutch family-based study, we assessed the relationships between 148 different plasma phospho- and sphingolipid species and depression/anxiety symptoms as measured by the Hospital Anxiety and Depression Scales (HADS-A and HADS-D) and the Centre for Epidemiological Studies Depression Scale (CES-D). We observed significant differences in plasma sphingomyelins (SPM), particularly the SPM 23:1/SPM 16:0 ratio, which was inversely correlated with depressive symptom scores. We observed a similar trend for plasma phosphatidylcholines (PC), particularly the molar proportion of PC O 36:4 and its ratio to ceramide CER 20:0. Absolute levels of PC O 36:4 were also associated with depression symptoms in an independent replication. To our knowledge this is the first study on depressive symptoms that focuses on specific phospho- and sphingolipid molecules in plasma rather than total PUFA concentrations. The findings of this lipidomic study suggests that plasma sphingomyelins and ether phospholipids should be further studied for their potential as biomarkers and for a better understanding of the underlying mechanisms of this systemic disease.


Neurobiology of Aging | 2010

The apolipoprotein E gene and its age-specific effects on cognitive function

Fan Liu; Luba M. Pardo; Maaike Schuur; Pascual Sánchez-Juan; Aaron Isaacs; Kristel Sleegers; Ingrid de Koning; Irina V. Zorkoltseva; Tatiana I. Axenovich; Jacqueline C. M. Witteman; A. Cecile J. W. Janssens; John C. van Swieten; Yurii S. Aulchenko; Ben A. Oostra; Cornelia van Duijn

The E4 allele of the apolipoprotein E gene (APOE) is a well-established determinant of Alzheimers disease but its relation to cognitive function is much less understood. We studied the age-specific effects of the APOE*E4 allele on cognitive function and cardiovascular risk factors in 2208 related individuals. APOE*E4 allele was significantly associated with reduced test scores for Adult Verbal Learning Test, particularly on the memory and learning sub domains, in persons older than 50 years of age. The effect of APOE*E4 was independent of the effect of APOE*E4 on vascular risk factors and most pronounced on learning ability. Our findings suggest that APOE*E4 has an effect on cognitive function predominantly in the elderly, independent of vascular risk factors.

Collaboration


Dive into the Ben A. Oostra's collaboration.

Top Co-Authors

Avatar

Cornelia van Duijn

Erasmus University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Yurii S. Aulchenko

Novosibirsk State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Najaf Amin

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Igor Rudan

University of Edinburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Albert Hofman

Battelle Memorial Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge